By: Marci Greenstein 14 December 2010 Emily Tarsell thought she had enough information about Gardasil — a new vaccine marketed to girls to prevent certain types of cervical cancer — when she agreed to have her daughter receive the vaccine. But after her third and last injection of Gardasil, in 2008, Christina Tarsell, […]
FDA Reviewers Endorse Gardasil for Anal Cancer Prevention
By: Emily P. Walker 15 November 2010 WASHINGTON — Merck’s quadrivalent human papillomavirus recombinant vaccine, Gardasil, appears safe and effective at preventing anal cancer in males and females ages 9 to 26, FDA reviewers said. The vaccine was approved in 2006 to treat genital warts and cervical, vulvar, and vaginal cancer in females ages 9 […]
To Gardasil or Not?
By: Tina Case 12 November 2010 I have been closely following the news on the cervical cancer vaccine known as Gardasil. Cervical cancer is the most prevalent cancer among women according to the WHO (World Health Organization). Cervical cancer is responsible for over a quarter million deaths every year. But it is important to note – 85% of those in […]
Gardasil Anal Cancer Indication to Face FDA Advisory Committee Scrutiny
By: S. Sutter 27 September 2010 Merck’s bid to further expand the label for its human papillomavirus vaccine Gardasil – this time for the prevention of anal cancer and anal dysplasia – will face FDA advisory committee scrutiny in November. The Vaccines and Related Biological Products Advisory Committee will meet on Nov. 17 to discuss […]
NCI on Cervical Cancer Prevention and HPV vaccines: What’s a Woman to do?
By: Norma Erickson 31 August 2010 The following is a direct quote from a recently revised copy of “Cervical Cancer Prevention, Health Professional Version,” published by the National Cancer Institute (NCI): “The finding of HPV viral DNA integrated in most cellular genomes of cervical carcinomas supports epidemiologic data linking this agent to cervical cancer however, […]
- « Previous Page
- 1
- …
- 80
- 81
- 82
